Arlington Heights, IL, Aug. 08, 2017 -- The American Society of Plastic Surgeons (ASPS) is proud to welcome Sientra, a leading medical aesthetics company, as a Platinum Level sponsor of Plastic Surgery The Meeting, which takes place October 6 – 10 in Orlando. The premier educational and networking event for board-certified plastic surgeons across the world, Plastic Surgery The Meeting is attended by more than 3,000 plastic surgeons, trainees and other allied health professionals interested in translating the continuing medical education and information they receive into their practices to improve patient care and outcomes.
|
|||
"Sientra has a long-standing commitment to patient safety, product quality and technological innovation,” said Debra Johnson, MD, president of the American Society of Plastic Surgeons. “We value their commitment to working exclusively with board-certified plastic surgeons and appreciate their continued support of the patient safety and enhanced quality-of-life outcomes we advance at Plastic Surgery The Meeting.”
Corporate partners at the Premier Support levels receive unprecedented opportunities to communicate with aesthetic and reconstructive plastic surgeons from around the world. The Platinum Level of support is intended for companies who want to stand apart from their competitors by demonstrating the highest level of commitment to the education of plastic surgeons and advancement of the specialty.
“We are excited to continue our long-standing partnership with ASPS, a society that shares our commitment to the specialty of board-certified plastic surgeons,” said Sientra Chairman and Chief Executive Officer, Jeff Nugent. “As we continue to build a diversified global aesthetics company, we appreciate the opportunities the partnership affords us and is increasingly important in building relationships with key aesthetic and reconstructive plastic surgeons.”
For more information, visit our Plastic Surgery The Meeting website.
About Sientra
Headquartered in Santa Barbara, California, Sientra is a medical aesthetics company committed to making a difference in patients’ lives by enhancing their body image, growing their self-esteem and restoring their confidence. The Company was founded to provide greater choice to board-certified plastic surgeons and patients in need of medical aesthetics products. The Company has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company sells its breast implants and breast tissue expanders exclusively to board-certified and board-admissible plastic surgeons and tailors its customer service offerings to their specific needs. The Company also offers a range of other aesthetic and specialty products including BIOCORNEUM®, the professional choice in scar management, and miraDry, the only FDA cleared device to reduce underarm sweat, odor and permanently reduce hair of all colors.
For more information about Sientra, visit www.sientra.com
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/0db87659-6991-4653-87a7-8fbf4b9ea857
Adam Ross American Society of Plastic Surgeons 773-332-4719 [email protected]


Palantir Stock Jumps After Strong Q4 Earnings Beat and Upbeat 2026 Revenue Forecast
NRW Holdings Shares Surge After Securing Major Rio Tinto Contract and New Project Wins
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
CK Hutchison Unit Launches Arbitration Against Panama Over Port Concessions Ruling
Google Cloud and Liberty Global Forge Strategic AI Partnership to Transform European Telecom Services
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Instagram Outage Disrupts Thousands of U.S. Users
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Qantas to Sell Jetstar Japan Stake as It Refocuses on Core Australian Operations 



